Works matching IS 03618609 AND DT 2015 AND VI 90 AND IP 4

Results: 26
    1
    2
    3
    4
    5

    Evidence gaps in the management of sickle cell disease: A summary of needed research.

    Published in:
    2015
    By:
    • Savage, William J.;
    • Buchanan, George R.;
    • Yawn, Barbara P.;
    • Afenyi-Annan, Araba N.;
    • Ballas, Samir K.;
    • Goldsmith, Jonathan C.;
    • Hassell, Kathryn L.;
    • James, Andra H.;
    • John-Sowah, Joylene;
    • Jordan, Lanetta;
    • Lottenberg, Richard;
    • Murad, M. Hassan;
    • Ortiz, Eduardo;
    • Tanabe, Paula J.;
    • Ware, Russell E.;
    • Lanzkron, Sophie M.
    Publication type:
    Editorial
    6

    Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 327, doi. 10.1002/ajh.23946
    By:
    • Maddocks, Kami;
    • Wei, Lai;
    • Rozewski, Darlene;
    • Jiang, Yao;
    • Zhao, Yuan;
    • Adusumilli, Mikhil;
    • Pierceall, William E.;
    • Doykin, Camille;
    • Cardone, Michael H.;
    • Jones, Jeffrey A.;
    • Flynn, Joseph;
    • Andritsos, Leslie A.;
    • Grever, Michael R.;
    • Byrd, John C.;
    • Johnson, Amy J.;
    • Phelps, Mitch A.;
    • Blum, Kristie A
    Publication type:
    Article
    7
    8
    9
    10

    All systems red.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 356, doi. 10.1002/ajh.23869
    By:
    • Karmacharya, Paras;
    • Donato, Anthony A;
    • Aryal, Madan Raj;
    • Pathak, Ranjan;
    • Goonewardene, Michael;
    • Valent, Peter
    Publication type:
    Article
    11
    12

    Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. E73, doi. 10.1002/ajh.23932
    By:
    • Holmström, Morten O.;
    • Gimsing, Peter;
    • Abildgaard, Niels;
    • Andersen, Niels F.;
    • Helleberg, Carsten;
    • Clausen, Niels Aage T.;
    • Klausen, Tobias W.;
    • Frederiksen, Mikael;
    • Kristensen, Dan L.;
    • Larsen, Herdis;
    • Pedersen, Per T.;
    • Andersen, Kristian Thidemann;
    • Pedersen, Robert Schou;
    • Jensen, Bo Amdi;
    • Gregersen, Henrik;
    • Vangsted, Annette J.
    Publication type:
    Article
    13
    14
    15
    16

    Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. E60, doi. 10.1002/ajh.23936
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kalapanida, Despina;
    • Pamboucas, Constantinos;
    • Kaldara, Elisavet;
    • Ntalianis, Argyrios;
    • Psimenou, Erasmia;
    • Toumanidis, Savvas T.;
    • Tasidou, Anna;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    17
    18
    19
    20
    21

    Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 282, doi. 10.1002/ajh.23923
    By:
    • Iriyama, Noriyoshi;
    • Fujisawa, Shin;
    • Yoshida, Chikashi;
    • Wakita, Hisashi;
    • Chiba, Shigeru;
    • Okamoto, Shinichiro;
    • Kawakami, Kimihiro;
    • Takezako, Naoki;
    • Kumagai, Takashi;
    • Inokuchi, Koiti;
    • Ohyashiki, Kazuma;
    • Taguchi, Jun;
    • Yano, Shingo;
    • Igarashi, Tadahiko;
    • Kouzai, Yasuji;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Sakamaki, Hisashi
    Publication type:
    Article
    22

    Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 276, doi. 10.1002/ajh.23924
    By:
    • Strati, Paolo;
    • Kantarjian, Hagop;
    • Ravandi, Farhad;
    • Nazha, Aziz;
    • Borthakur, Gautam;
    • Daver, Naval;
    • Kadia, Tapan;
    • Estrov, Zeev;
    • Garcia-Manero, Guillermo;
    • Konopleva, Marina;
    • Rajkhowa, Trivikram;
    • Durand, Menda;
    • Andreeff, Michael;
    • Levis, Mark;
    • Cortes, Jorge
    Publication type:
    Article
    23
    24

    G-CSF Priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 295, doi. 10.1002/ajh.23927
    By:
    • Becker, Pamela S.;
    • Medeiros, Bruno C.;
    • Stein, Anthony S.;
    • Othus, Megan;
    • Appelbaum, Frederick R.;
    • Forman, Stephen J.;
    • Scott, Bart L.;
    • Hendrie, Paul C.;
    • Gardner, Kelda M.;
    • Pagel, John M.;
    • Walter, Roland B.;
    • Parks, Cynthia;
    • Wood, Brent L.;
    • Abkowitz, Janis L.;
    • Estey, Elihu H.
    Publication type:
    Article
    25

    Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 288, doi. 10.1002/ajh.23928
    By:
    • Them, Nicole C.C.;
    • Bagienski, Klaudia;
    • Berg, Tiina;
    • Gisslinger, Bettina;
    • Schalling, Martin;
    • Chen, Doris;
    • Buxhofer-Ausch, Veronika;
    • Thaler, Josef;
    • Schloegl, Ernst;
    • Gastl, Guenther A.;
    • Wolf, Dominik;
    • Strecker, Karin;
    • Egle, Alexander;
    • Melchardt, Thomas;
    • Burgstaller, Sonja;
    • Willenbacher, Ella;
    • Zagrijtschuk, Oleh;
    • Klade, Christoph;
    • Greil, Richard;
    • Gisslinger, Heinz
    Publication type:
    Article
    26